Buy Stock

TRENTON, N.J. -- Teva Pharmaceutical said Friday that it would buy rival generic drug maker Barr Pharmaceuticals for nearly $7.5 billion in a move that will boost Teva's dominance as the world's biggest generic drug maker. The deal continues ...

The most common, and most ignored, piece of investment advice ever? Buy low, of course. We know this to be true because there was a stunning $70-billion sitting in safe but low-paying money market funds at midyear, almost 45 per cent more than in the ...